Vaxcyte (PCVX)
(Delayed Data from NSDQ)
$79.35 USD
+1.21 (1.55%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $79.24 -0.11 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -1.01 |
EPS Last Quarter | -1.10 |
Last EPS Surprise | 3.51% |
ABR | 1.11 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.33 |
Next Year | -4.49 |
EPS (TTM) | -4.68 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.01 | -1.02 | -4.33 | -4.49 |
# of Estimates | 3 | 2 | 5 | 4 |
Most Recent Consensus | -0.88 | -0.94 | -4.07 | -3.22 |
High Estimate | -0.88 | -0.94 | -3.78 | -3.22 |
Low Estimate | -1.09 | -1.10 | -5.10 | -5.40 |
Year ago EPS | -0.91 | -1.82 | -4.14 | -4.33 |
Year over Year Growth Est. | -10.99% | 43.96% | -4.59% | -3.58% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 4 | 2 |
Down Last 60 Days | 1 | 1 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.01 | -1.02 | -4.33 | -4.49 |
7 Days Ago | -1.01 | -1.02 | -4.33 | -4.49 |
30 Days Ago | -0.87 | -0.92 | -3.93 | -4.13 |
60 Days Ago | -0.89 | -0.94 | -3.96 | -4.17 |
90 Days Ago | -0.89 | -0.94 | -3.96 | -4.17 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.01 | -1.02 | -4.34 | -4.53 |
Zacks Consensus Estimate | -1.01 | -1.02 | -4.33 | -4.49 |
Earnings ESP | 0.00% | 0.00% | -0.29% | -1.08% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.10 | -0.85 | -1.82 | -0.91 | NA |
Estimate | -1.14 | -1.11 | -0.90 | -0.79 | NA |
Difference | 0.04 | 0.26 | -0.92 | -0.12 | -0.19 |
Surprise | 3.51% | 23.42% | -102.22% | -15.19% | -22.62% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more